These Guidelines on the management of latent tuberculosis infection were developed in accordance to the requirements and recommended process of the WHO Guideline Review Committee, and provide public health approach guidance on evidence-based practices for testing, treating and managing LTBI in infec...
FAO and WHO undertook a risk assessment of Salmonella in eggs and broiler chickens in response to requests for expert advice on this issue from their member countries and from the Codex Alimentarius Commission. Guidance on this issue is needed, as salmonellosis is a leading cause of foodborne illnes...
The WHO Expert Committee on Biological Standardization met in Geneva from 29 October to 2 November 2018. The meeting was opened on behalf of the Director-General of WHO by Dr Soumya Swaminathan, Deputy Director- General for Programmes. Dr Swaminathan welcomed the Committee, meeting participants and...
International travel has become increasingly easy and readily available. Ever greater numbers of people are using international air travel for many reasons including business, tourism, immigration, asylum seeking or humanitarian activities. There is a potential risk of transmission of tuberculosis (...
Conventional light microscopy of Ziehl-Neelsen-stained smears prepared directly from sputum specimens is the most widely available test for diagnosis of tuberculosis (TB) in resource-limited settings. Ziehl-Neelsen microscopy is highly specific, but its sensitivity is variable (20-80%) and is signif...
This bulletin serves to inform all stakeholders at community, district, and national levels on suspected disease trends, public health surveillance, and interventions undertaken in detecting, preventing, and responding to public health events in Uganda every week.
The survey established that DS-TB patients spent on average 369 United States dollars (USD) on TB related care per episode while MDR-TB patients spend on average 3722 USD. In the prediagnosis period, major cost drivers for both types of TB were medical and travel costs with both costs being higher f...
This publication provides guiding principles for WHO Member States to promote the involvement of people with tuberculosis (TB) and the community in TB care and prevention. These recommendations are designed to support health policy-makers - and patients�� groups and local partners - in including com...
This document is an evidence-based policy for the implementation of sound tuberculosis (TB) infection control by all stakeholders. TB infection control is a combination of measures aimed at minimizing the risk of TB transmission within populations. The foundation of infection control is early and ra...
Tuberculosis (TB) remains a disease of great public health concern in Uganda. The country is one of the 30 high TB/HIV burden countries in the world. The prevalence of TB estimated in the recently concluded National TB prevalence survey is almost two times higher than had previously been estimated (...
This bulletin serves to inform all stakeholders at community, district and national levels on suspected disease trends, public health surveillance and interventions undertaken in detecting, preventing and responding to public health events in Uganda on a weekly basis.
This publication is about the TB statistics in Uganda.
Hepatitis is inflammation of the liver. Hepatitis can be caused by infectious such as viruses, bacteria and non-infectious agents such as toxins, drugs, alcohol. Viral hepatitis is inflammation of the liver caused by viruses. The commonest causes of viral hepatitis include one of the five heterotype...
As countries discontinue COVID-19-specific reporting and integrate respiratory disease surveillance, WHO will use all available sources to continue monitoring the COVID-19 epidemiological situation, especially data on impact. COVID-19 remains a major threat and WHO urges Member States to maintain, n...
The Sustainable Development Goals (SDGs) for 2030 were adopted by the United Nations in 2015. One of the targets is to end the global TB epidemic. The WHO End TB Strategy, approved by the World Health Assembly in 2014, calls for a 90% reduction in TB deaths and an 80% reduction in the TB incidence r...
Uganda is faced with frequent outbreaks of emerging diseases and high burden of other endemic conditions, including cholera, all of which require dedicated resources for their prevention and control. However, like many developing countries, Uganda is resource constrained, has an inadequate health de...
Non-communicable diseases, injuries, and mental health conditions (NCDI/MH) are substantial diseases and economic threats across African Union (AU) Member States (MS). The conditions are estimated to disable and prematurely end millions of lives across Africa each year. They constitute a serious imp...
In 2006, the Special Session of African Union Health Ministers adopted the Maputo Plan of Action for implementing the Continental Policy Framework on sexual and reproductive health and rights (SRHR), which expired at the end of 2015. The goal was for all stakeholders and partners to join forces and...
Anthrax essentially ceased to be regarded as a disease of major health or economic importance after the enormous successes of Max Sterne��s veterinary vaccine developed in the 1930s, and subsequent analogs in the former Soviet Union, in dramatically reducing the incidence of the disease in livestock...
Management of MDR-TB: a fi eld guide was created to help health workers carry out these tasks. It is a job aid that medical offi cers and TB nurses are meant use frequently during the day for quick reference. This module is closely related to other clinical guideline modules in the Integrated Manage...
